| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 1666 |
| 1 | ASPIRIN | 1584 |
| 2 | ASPIRIN 81 MG | 1552 |
| 3 | ASPIRIN 325 MG | 1550 |
| 4 | APIXABAN | 1132 |
| 5 | CLOPIDOGREL | 989 |
| 6 | FUROSEMIDE | 938 |
| 7 | PREDNISOLONE | 741 |
| 8 | PREDNISOLONE ORAL | 741 |
| 9 | PREDNISOLONE ORAL SOLUTION | 741 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANDEXANET ALFA | 54 | 0.0762 |
| 1 | EDARAVONE | 99 | 0.0617 |
| 2 | ANAGRELIDE HYDROCHLORIDE | 51 | 0.0434 |
| 3 | EDOXABAN TOSYLATE | 273 | 0.0400 |
| 4 | ARGATROBAN | 50 | 0.0334 |
| 5 | DAPRODUSTAT | 59 | 0.0296 |
| 6 | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE | 9 | 0.0281 |
| 7 | PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, PROTEIN C, PROTEIN S HUMAN, AND WATER | 14 | 0.0258 |
| 8 | LECANEMAB | 98 | 0.0257 |
| 9 | BROMPHENIRAMINE MALEATE | 9 | 0.0251 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 2769 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2290 |
| 2 | Corticosteroid [EPC] | 1919 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 1625 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 1046 |
| 5 | Proton Pump Inhibitor [EPC] | 1021 |
| 6 | Loop Diuretic [EPC] | 1019 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 979 |
| 8 | Kinase Inhibitor [EPC] | 931 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 917 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Non-Standardized Animal Skin Allergenic Extract [EPC] | 2 | 0.1176 |
| 1 | Non-Standardized Animal Hair Allergenic Extract [EPC] | 1 | 0.0500 |
| 2 | Interleukin-5 Antagonist [EPC] | 26 | 0.0378 |
| 3 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 66 | 0.0291 |
| 4 | Amyloid Beta-directed Antibody [EPC] | 98 | 0.0256 |
| 5 | Nucleoside Analog Antifungal [EPC] | 30 | 0.0212 |
| 6 | Humanized Monoclonal Antibody Fragment [EPC] | 29 | 0.0202 |
| 7 | Phosphodiesterase 3 Inhibitor [EPC] | 118 | 0.0189 |
| 8 | alpha-Glucosidase Inhibitor [EPC] | 86 | 0.0176 |
| 9 | Complement C5 Inhibitor [EPC] | 2 | 0.0165 |